Dolby Laboratories' (DLB) Outperform Rating Reaffirmed at Barrington Research

Barrington Research restated their outperform rating on shares of Dolby Laboratories (NYSE:DLB - Free Report) in a report published on Monday morning,Benzinga reports. The brokerage currently has a $100.00 price target on the electronics maker's stock.

A number of other research firms also recently issued reports on DLB. StockNews.com upgraded shares of Dolby Laboratories from a "buy" rating to a "strong-buy" rating in a report on Wednesday, December 4th. Rosenblatt Securities restated a "buy" rating and set a $100.00 price objective on shares of Dolby Laboratories in a report on Thursday.

Dolby Laboratories Stock Performance

Dolby Laboratories stock traded up $1.50 during trading on Monday, hitting $81.21. The company's stock had a trading volume of 245,106 shares, compared to its average volume of 433,291. The stock's fifty day moving average is $78.79 and its 200 day moving average is $75.60. Dolby Laboratories has a 1-year low of $66.35 and a 1-year high of $85.30. The stock has a market capitalization of $7.75 billion, a price-to-earnings ratio of 29.97 and a beta of 0.98.

Dolby Laboratories Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 10th. Investors of record on Tuesday, December 3rd were issued a $0.33 dividend. This is a positive change from Dolby Laboratories's previous quarterly dividend of $0.30. The ex-dividend date of this dividend was Tuesday, December 3rd. This represents a $1.32 annualized dividend and a yield of 1.63%. Dolby Laboratories's dividend payout ratio (DPR) is presently 48.71%.

Insider Buying and Selling at Dolby Laboratories

In other Dolby Laboratories news, SVP John D. Couling sold 50,000 shares of the company's stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of $80.04, for a total value of $4,002,000.00. Following the completion of the transaction, the senior vice president now owns 106,806 shares in the company, valued at $8,548,752.24. This represents a 31.89 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Peter C. Gotcher sold 6,079 shares of Dolby Laboratories stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $78.96, for a total transaction of $479,997.84. Following the sale, the director now owns 37,593 shares in the company, valued at $2,968,343.28. This represents a 13.92 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 135,917 shares of company stock valued at $10,877,739 over the last ninety days. Corporate insiders own 38.39% of the company's stock.

Institutional Investors Weigh In On Dolby Laboratories

A number of large investors have recently added to or reduced their stakes in the company. Mather Group LLC. boosted its position in Dolby Laboratories by 36.8% in the 4th quarter. Mather Group LLC. now owns 528 shares of the electronics maker's stock valued at $41,000 after buying an additional 142 shares during the last quarter. Boston Trust Walden Corp lifted its stake in shares of Dolby Laboratories by 0.9% in the fourth quarter. Boston Trust Walden Corp now owns 1,084,700 shares of the electronics maker's stock worth $84,715,000 after acquiring an additional 9,624 shares in the last quarter. Willis Investment Counsel boosted its holdings in Dolby Laboratories by 3.5% in the fourth quarter. Willis Investment Counsel now owns 6,157 shares of the electronics maker's stock valued at $481,000 after purchasing an additional 206 shares during the last quarter. Diversified Investment Strategies LLC grew its stake in Dolby Laboratories by 0.3% during the 4th quarter. Diversified Investment Strategies LLC now owns 59,395 shares of the electronics maker's stock valued at $4,639,000 after purchasing an additional 195 shares in the last quarter. Finally, Pacer Advisors Inc. increased its holdings in Dolby Laboratories by 211.8% during the 4th quarter. Pacer Advisors Inc. now owns 41,223 shares of the electronics maker's stock worth $3,220,000 after purchasing an additional 28,001 shares during the last quarter. 58.56% of the stock is owned by institutional investors and hedge funds.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.